StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
PAVMPAVmed Inc.
stockpulse.co.kr
Nasdaq
$2.17▼ 2.69%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $15.5MShares out 7.2M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

2
  • 1d agoAfter-hours26.10.24 05:36
    SCHEDULE 13G/AOwnership#●●●

    PAVmed Inc.

    Craig Kallman, a major shareholder of PAVmed Inc., has filed a SCHEDULE 13G/A to report changes in beneficial ownership. This filing provides an update on the investor's equity position in the company.…more

    $2.17-2.69%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 2d agoAfter-hours26.10.23 06:28
    8-KKey event

    PAVmed Inc.

    PAVmed's subsidiary, Lucid Diagnostics, has completed a $15 million offering of Series C Convertible Preferred Stock to accredited investors. The transaction involved the sale of 15,000 shares at a price of $1,000 per share, with a registration rights agreement executed to cover the resale of common stock issuable upon conversion.…more

    $2.17-2.69%vs prev close
    View filingShare

1 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 2d agoAfter-hours26.10.23 05:28
    Bullish#●●●#●●●#●●●

    Lucid Diagnostics Secures Medicare Payments and $15M Private Placement

    Lucid Diagnostics has begun receiving Medicare payments for its EsoGuard test and closed a $15 million private placement of Series C convertible preferred stock. The proceeds are intended to accelerate commercial operations, though the conversion terms introduce potential equity dilution.…more

    $2.17-2.69%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.10Pre-market26.09.10 19:04

    ●●●●●●●● ●●●●● ●●●●●●

    PAVmed has entered into an agreement to sell up to $9.4 million of its common stock through an at-the-market offering. This capital-raising move may lead to shareholder dilution, which is typically viewed as a bearish signal for the stock price.…more

    $2.17-2.69%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →